BDBM103757 US8551978, I-26::US8816088, I-26::US9394275, I-26::US9572802, Compound I-26::US9682957, I-26

SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cc(ccc1C)C(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1

InChI Key InChIKey=AASAEQLTIUBPQN-QLKFWGTOSA-N

Data  5 KI  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 103757   

TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Theravance

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataKi:  0.200nMAssay Description:Radioligand binding assay using muscarinic receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Theravance

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataKi:  0.200nMAssay Description:Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell me...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Theravance

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataKi:  0.200nM ΔG°:  -13.8kcal/moleT: 2°CAssay Description:Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Theravance

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataKi:  0.200nMAssay Description:compounds were performed with [3H]NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a con...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Theravance

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataKi:  0.200nMAssay Description:Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Theravance Respiratory

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataEC50:  1nMT: 2°CAssay Description:cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Theravance Respiratory

US Patent
LigandPNGBDBM103757(US8551978, I-26 | US8816088, I-26 | US9394275, I-2...)
Affinity DataEC50:  1nMT: 2°CAssay Description:cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...More data for this Ligand-Target Pair
In DepthDetails US Patent